UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
Public ClinicalTrials.gov record NCT06737380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of Subcutaneous Administration of Umbilical Cord Derived - Mesenchymal Stromal Cell Therapy in Addition to Standard of Care as A Treatment For Active Systemic Lupus Erythematosus
Study identification
- NCT ID
- NCT06737380
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- LiveKidney.Bio
- Industry
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Interventions
- Physical examination Diagnostic Test
- Electrocardiogram Diagnostic Test
- SF-36 questionnaire Other
- Clinical laboratory evaluations - Serology Diagnostic Test
- Clinical laboratory evaluations - Biochemistry Diagnostic Test
- Clinical laboratory evaluations - Hematology Diagnostic Test
- Pregnancy Test Diagnostic Test
- Urinalysis Diagnostic Test
- SLE activity evaluation Diagnostic Test
- SLE biomarker profiling Diagnostic Test
- Cytokines and chemokine profiling Diagnostic Test
- single dose of UC-MSCs Biological
- PROMIS instruments Other
Diagnostic Test · Other · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 6, 2025
- Primary completion
- May 31, 2026
- Completion
- Jun 30, 2026
- Last update posted
- Sep 10, 2025
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06737380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06737380 live on ClinicalTrials.gov.